Daniel Cejka

Head of Department

Ordensklinikum Linz Elisabethinen

Austria

Research Interests

Explore related searches

Professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Raute Sunder-Plassmann

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Michael Mengel

Professor

University of Alberta

CANADA

View details

Walther Parson

ao.Univ.-Prof.

Medical University of Innsbruck

AUSTRIA

View details

Peter Wolf

AUSTRIA

View details

Benjamin Adam

Associate Professor

University of Alberta

CANADA

View details

Heidrun Kerschner

Ordensklinikum Linz Elisabethinen

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Cejka

Research Interests

Explore related searches

Contact this professor

Articles (10)

Citrate-Buffered, Magnesium-Enriched Dialysate on Calcification Propensity in Hemodialysis Patients – The CitMag Study

Cumulative UV Exposure or a Modified SCINEXA™-Skin Aging Score Do Not Play a Substantial Role in Predicting the Risk of Developing Keratinocyte Cancers after Solid Organ Transplantation—A Case Control Study

Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring.

Humoral response after a third and fourth dose of mRNA-based SARS-CoV-2 vaccine in previously seronegative kidney transplant recipients.

[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].

Value of SGLT-2 inhibitors in the treatment of chronic kidney disease : Clinical and practical implications.

Coping with a lack of evidence: living-donor kidney transplantation in the initial phase of the SARS-CoV-2 pandemic.

Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells.

Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease

Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.

Collaborators (6)

Raute Sunder-Plassmann

Michael Mengel

Walther Parson

Peter Wolf

Benjamin Adam

Heidrun Kerschner

Make your next move.